Advertisement

Indoco Remedies profit increased 322.16% in (Q2) FY 2019-20

Source: 
Team Infinities:

Indoco Remedies Limited NSE Symbol:INDOCO, BSE Security Code:532612 has declared its 2nd(second) quarter un-audited Consolidated financial report from the month of July, 2019 to the month of September, 2019; for the fiscal year 2019-20.

Revenue Reported by Indoco Remedies Limited for Second Quarter FY, 2019-20
Current Quarter (July, 2019 - September, 2019) Previous Quarter (April, 2019 - June, 2019) Corresponding Quarter (July, 2018 - September, 2018) 6 Months Ended (April, 2019 - September, 2019) Corresponding 6 Months Ended (April, 2018 - September, 2018)
293.15 253.32 236.31 546.47 454.41
Calculated Revenue of Indoco Remedies Limited for Second Quarter FY, 2019-20
Current(September, 2019) VS Previous(June, 2019) Current(September, 2019) VS Corresponding(September, 2018) 6 months Ended(April, 2019 - September, 2019) VS Corresponding 6 months Ended(April, 2018 - September, 2018)
Change Change % Change Change % Change Change %
39.83 15.72%(Revenue Increase) 56.84 24.05%(Revenue Increase) 92.06 20.26%(Revenue Increase)

Revenue: Indoco Remedies Limited's financial report shows that the company's revenue increased by 15.72% in QoQ(Quarter on Quarter) / current quarter(July, 2019 - September, 2019) for revenue increase of Rs.39.83 crores, as the company posted revenue of Rs.293.15 crores; in compare to previous quarter(April, 2019 - June, 2019) when the company reported revenue of Rs.253.32 crores.
The result also shows that the company's revenue increased by 24.05% in YoY(Year over Year) / in current quarter(July, 2019 - September, 2019) for revenue increase of Rs.56.84 crores; in compare to corresponding quarter(July, 2018 - September, 2018) when the company posted revenue of Rs.236.31 crores.
The company also reported that its revenue increased by 20.26% in 6 months end(April, 2019 - September, 2019) for revenue increase of Rs.92.06 crores, since the company reported revenue of Rs.546.47 crores; in compare to corresponding 6 months end(April, 2018 - September. 2018) when the company posted revenue of Rs.454.41 crores.

Gross Margin(%) Reported by Indoco Remedies Limited for Second Quarter FY, 2019-20
Current Quarter (July, 2019 - September, 2019) Previous Quarter (April, 2019 - June, 2019) Corresponding Quarter (July, 2018 - September, 2018) 6 Months Ended (April, 2019 - September, 2019) Corresponding 6 Months Ended (April, 2018 - September, 2018)
63.98 68.74 69.30 66.19 70.56
Calculated Gross Margin(%) of Indoco Remedies Limited for Second Quarter FY, 2019-20
Current(September, 2019) VS Previous(June, 2019) Current(September, 2019) VS Corresponding(September, 2018) 6 months Ended(April, 2019 - September, 2019) VS Corresponding 6 months Ended(April, 2018 - September, 2018)
Change Change % Change Change % Change Change %
4.76 6.92%(GM Decrease) 5.32 7.68%(GM Decrease) 4.37 6.20%(GM Decrease)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 6.92% in QoQ(Quarter on Quarter) / current quarter(July, 2019 - September, 2019) for 4.76% GM decrease, as the company reported 63.98% GM; in compare to previous quarter(April, 2019 - June, 2019) when the company reported 68.74% GM.
The result also indicates, the company's GM decreased by 7.68% in YoY(Year over Year) / in current quarter(July, 2019 - September, 2019) for 5.32% GM decrease; in compare to corresponding quarter(July, 2018 - September, 2018) when the company reported 69.30% GM.
The company also reported that its GM decreased by 6.20% in 6 months end(April, 2019 - September, 2019) for 4.37% GM decrease, since the company reported 66.19% GM; in compare to corresponding 6 months end(April, 2018 - September. 2018) when the company reported 70.56% GM.

EBITDA Reported by Indoco Remedies Limited for Second Quarter FY, 2019-20
Current Quarter (July, 2019 - September, 2019) Previous Quarter (April, 2019 - June, 2019) Corresponding Quarter (July, 2018 - September, 2018) 6 Months Ended (April, 2019 - September, 2019) Corresponding 6 Months Ended (April, 2018 - September, 2018)
33.21 23.06 12.47 56.27 24.18
Calculated EBITDA of Indoco Remedies Limited for Second Quarter FY, 2019-20
Current(September, 2019) VS Previous(June, 2019) Current(September, 2019) VS Corresponding(September, 2018) 6 months Ended(April, 2019 - September, 2019) VS Corresponding 6 months Ended(April, 2018 - September, 2018)
Change Change % Change Change % Change Change %
10.15 44.02%(EBITDA Increase) 20.74 166.32%(EBITDA Increase) 32.09 132.71%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 44.02% in QoQ(Quarter on Quarter) / current quarter(July, 2019 - September, 2019) for EBITDA increase of Rs.10.15 crores, as the company posted EBITDA of Rs.33.21 crores; in compare to previous quarter(April, 2019 - June, 2019) when the company reported EBITDA of Rs.23.06 crores.
The result also shows that the company's EBITDA increased by 166.32% in YoY(Year over Year) / in current quarter(July, 2019 - September, 2019) for EBITDA increase of Rs.20.74 crores; in compare to corresponding quarter(July, 2018 - September, 2018) when the company posted EBITDA of Rs.12.47 crores.
The company also reported that its EBITDA increased by 132.71% in 6 months end(April, 2019 - September, 2019) for EBITDA increase of Rs.32.09 crores, since the company reported EBITDA of Rs.56.27 crores; in compare to corresponding 6 months end(April, 2018 - September. 2018) when the company posted EBITDA of Rs.24.18 crores.

Profit and Loss Reported by Indoco Remedies Limited for Second Quarter FY, 2019-20
Current Quarter (July, 2019 - September, 2019) Previous Quarter (April, 2019 - June, 2019) Corresponding Quarter (July, 2018 - September, 2018) 6 Months Ended (April, 2019 - September, 2019) Corresponding 6 Months Ended (April, 2018 - September, 2018)
7.81(Profit ) 1.85(Profit ) 7.45(Loss ) 9.66(Profit ) 19.65(Loss )
Calculated Profit and Loss of Indoco Remedies Limited for Second Quarter FY, 2019-20
Current(September, 2019) VS Previous(June, 2019) Current(September, 2019) VS Corresponding(September, 2018) 6 months Ended(April, 2019 - September, 2019) VS Corresponding 6 months Ended(April, 2018 - September, 2018)
Change Change % Change Change % Change Change %
5.96 322.16%(Profit Increase) 15.26 204.83%(Profit Increase) 29.31 149.16%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 322.16% in QoQ(Quarter on Quarter) / current quarter(July, 2019 - September, 2019) for profit increase of Rs.5.96 crores, as the company posted profit of Rs.7.81 crores; in compare to previous quarter(April, 2019 - June, 2019) when the company reported profit of Rs.1.85 crores.
The result also shows that the company's profit increased by 204.83% in YoY(Year over Year) / in current quarter(July, 2019 - September, 2019) for profit increase of Rs.15.26 crores; in compare to corresponding quarter(July, 2018 - September, 2018) when the company posted loss of Rs.7.45 crores.
The company also reported that its profit increased by 149.16% in 6 months end(April, 2019 - September, 2019) for profit increase of Rs.29.31 crores, since the company reported profit of Rs.9.66 crores; in compare to corresponding 6 months end(April, 2018 - September. 2018) when the company posted loss of Rs.19.65 crores.

EPS Reported by Indoco Remedies Limited for Second Quarter FY, 2019-20
Current Quarter (July, 2019 - September, 2019) Previous Quarter (April, 2019 - June, 2019) Corresponding Quarter (July, 2018 - September, 2018) 6 Months Ended (April, 2019 - September, 2019) Corresponding 6 Months Ended (April, 2018 - September, 2018)
0.85 0.20 0.81(Negative) 1.05 2.13(Negative)
Calculated EPS of Indoco Remedies Limited for Second Quarter FY, 2019-20
Current(September, 2019) VS Previous(June, 2019) Current(September, 2019) VS Corresponding(September, 2018) 6 months Ended(April, 2019 - September, 2019) VS Corresponding 6 months Ended(April, 2018 - September, 2018)
Change Change % Change Change % Change Change %
0.65 325.00%(EPS Increase) 1.66 204.94%(EPS Increase) 3.18 149.30%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 325.00% in QoQ(Quarter on Quarter) / current quarter(July, 2019 - September, 2019) for EPS increase of Rs.0.65, as the company posted EPS of Rs.0.85; in compare to previous quarter(April, 2019 - June, 2019) when the company reported EPS of Rs.0.20.
The result also shows that the company's EPS increased by 204.94% in YoY(Year over Year) / in current quarter(July, 2019 - September, 2019) for EPS increase of Rs.1.66; in compare to corresponding quarter(July, 2018 - September, 2018) when the company posted Negative EPS of Rs.0.81.
The company also reported that its EPS increased by 149.30% in 6 months end(April, 2019 - September, 2019) for EPS increase of Rs.3.18, since the company reported EPS of Rs.1.05; in compare to corresponding 6 months end(April, 2018 - September. 2018) when the company posted Negative EPS of Rs.2.13.

Assets Reported by Indoco Remedies Limited for Second Quarter FY, 2019-20
Details Non-current Assets Current Assets
Current Quarter(September, 2019) Previous Year End(March, 2019) Current Quarter(September, 2019) Previous Year End(March, 2019)
Reported 711.07 720.00 598.98 538.05
  Change Change % Change Change %
Calculated 8.93 1.24%(Assets Decrease) 60.93 11.32%(Assets Increase)

Assets:The company reported its non-current assets decreased by 1.24% in current quarter(September, 2019) for non-current assets decrease of Rs.8.93 crores, since the company reported net non-current assets of Rs.711.07 crores; in compare to previous year end(March, 2019) when the company reported net non-current assets of Rs.720.00 crores.
The balance sheet of the company also shows that, its current assets increased by 11.32% in current quarter(September, 2019) for current assets increase of Rs.60.93 crores, as the company reported net current assets of Rs.598.98 crores; against previous year end(March, 2019) when the company reported net current assets of Rs.538.05 crores.

Liabilities Reported by Indoco Remedies Limited for Second Quarter FY, 2019-20
Details Non-current Liabilities Current Liabilities
Current Quarter(September, 2019) Previous Year End(March, 2019) Current Quarter(September, 2019) Previous Year End(March, 2019)
Reported 129.40 151.93 513.89 445.50
  Change Change % Change Change %
Calculated 22.53 14.83%(Liabilities Decrease) 68.39 15.35%(Liabilities Increase)

Liabilities:The company reported its non-current liabilities decreased by 14.83% in current quarter(September, 2019) for non-current liabilities decrease of Rs.22.53 crores, since the company reported net non-current liabilities of Rs.129.40 crores; in compare to previous year end(March, 2019) when the company reported net non-current liabilities of Rs.151.93 crores.
The balance sheet of the company also shows that, its current liabilities increased by 15.35% in current quarter(September, 2019) for current liabilities increase of Rs.68.39 crores, as the company reported net current liabilities of Rs.513.89 crores; against previous year end(March, 2019) when the company reported net current liabilities of Rs.445.50 crores.


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

Add new comment

Comment Editor

  • No HTML tags allowed.
CAPTCHA
Please verify you are a human